Amphera B.V. logo

Amphera B.V.

Amphera B.V. is a clinical stage company developing autologus dendritic cell immunotherapies for malignant mesothelioma and other cancers.

Amphera is spin-off company of Erasmus MC; The Erasmus University Medical Center based in Rotterdam, Netherlands, affiliated with Erasmus University and is the largest and one of the most authoritative scientific University Medical Centers in Europe.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.amphera.nl
Founded2012
Disease Focus
Development StageClinical
STOCK CODENon Listed
Address
Onderwijsboulevard 225 5223
DE s-Hertogenbosch
Netherlands
Email
Contact Number
+31 73 627 4520

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]

Erasmus MC researchers developed a technique to grow mesothelioma tumor cells, which other wise was difficult and even impossible to harvest these tumor cells from the body, making them unavaliable for immunotherapy. Thus, activating the immune system by using the bodys own immune cells (dendritic cells) and the bodys own tumor cells is a technique that has been developed by Erasmus MC and has been shown to be effective in treating malignant mesothelioma.